Metabolic profiling of rupestonic acid post intranasal administration in rats
Rupestonic acid shows favorable metabolic stability with low metabolic rate and long half-life after intranasal administration in rats.
Company
Pharmaceutical intelligence for Anti-inflammatory with 1 indexed intelligence signal across regulatory, clinical, competitive, and market developments.
No catalysts indexed for this entity yet.
No signals indexed for this entity yet.
No signals indexed for this entity yet.
No related entities indexed yet.
Newsletter
Concise strategic intelligence on regulatory, clinical, competitive, and market developments — free to subscribe.
No paywall. No spam. Unsubscribe anytime.